Artivion, Inc. (AORT)
NYSE: AORT · Real-Time Price · USD
28.77
-0.14 (-0.48%)
At close: May 12, 2025, 4:00 PM
28.77
0.00 (0.00%)
After-hours: May 12, 2025, 7:00 PM EDT
Artivion Market Cap
Artivion has a market cap or net worth of $1.23 billion as of May 12, 2025. Its market cap has increased by 42.46% in one year.
Market Cap
1.23B
Enterprise Value
1.55B
1-Year Change
42.46%
Ranking
Category
Stock Price
$28.77
Market Cap Chart
Since December 1, 1998, Artivion's market cap has increased from $143.30M to $1.23B, an increase of 757.33%. That is a compound annual growth rate of 8.46%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 9, 2025 | 1.23B | 3.00% |
Dec 31, 2024 | 1.20B | 63.31% |
Dec 29, 2023 | 733.90M | 50.14% |
Dec 30, 2022 | 488.80M | -38.93% |
Dec 31, 2021 | 800.40M | -12.75% |
Dec 31, 2020 | 917.40M | -9.70% |
Dec 31, 2019 | 1.02B | -3.16% |
Dec 31, 2018 | 1.05B | 63.74% |
Dec 29, 2017 | 640.70M | 1.86% |
Dec 30, 2016 | 629.00M | 105.09% |
Dec 31, 2015 | 306.70M | -3.13% |
Dec 31, 2014 | 316.60M | 3.40% |
Dec 31, 2013 | 306.20M | 79.06% |
Dec 31, 2012 | 171.00M | 26.57% |
Dec 30, 2011 | 135.10M | -11.41% |
Dec 31, 2010 | 152.50M | -16.53% |
Dec 31, 2009 | 182.70M | -33.13% |
Dec 31, 2008 | 273.20M | 24.81% |
Dec 31, 2007 | 218.90M | 14.91% |
Dec 29, 2006 | 190.50M | 135.77% |
Dec 30, 2005 | 80.80M | -51.03% |
Dec 31, 2004 | 165.00M | 44.74% |
Dec 31, 2003 | 114.00M | -14.73% |
Dec 31, 2002 | 133.70M | -76.39% |
Dec 31, 2001 | 566.30M | 0.23% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 675.56B |
Johnson & Johnson | 371.89B |
UnitedHealth Group | 342.90B |
AbbVie | 337.79B |
Novo Nordisk | 297.79B |
Abbott Laboratories | 230.35B |
Novartis AG | 214.71B |
AstraZeneca | 211.14B |